Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Global Clinical Trials Review, H2, 2014

GlobalData's clinical trial report, “Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Global Clinical Trials Review, H2, 2014" provides data on the Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts. Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

– Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each

– Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type

– Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

– Understand the dynamics of a particular indication in a condensed manner

– Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more

– Obtain discontinued trial listing for trials across the globe

– Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Introduction 6

Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection 6

Report Guidance 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Clinical Trials by G7 Countries: Proportion of Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection to Infectious Disease Clinical Trials 13

Clinical Trials by Phase in G7 Countries 14

Clinical Trials in G7 Countries by Trial Status 15

Clinical Trials by E7 Countries: Proportion of Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection to Infectious Disease Clinical Trials 16

Clinical Trials by Phase in E7 Countries 17

Clinical Trials in E7 Countries by Trial Status 18

Clinical Trials by Phase 19

In Progress Trials by Phase 20

Clinical Trials by Trial Status 21

Clinical Trials by End Point Status 22

Unaccomplished Trials of Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection 23

Subjects Recruited Over a Period of Time 24

Clinical Trials by Sponsor Type 25

Prominent Sponsors 26

Top Companies Participating in Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics Clinical Trials 27

Prominent Drugs 28

Clinical Trial Profiles 29

Clinical Trial Overview of Top Companies 29

Pharmstandard 29

Clinical Trial Overview of Pharmstandard 29

Hemispherx Biopharma, Inc. 30

Clinical Trial Overview of Hemispherx Biopharma, Inc. 30

Clinical Trial Overview of Top Institutes / Government 31

The National Institute of Allergy and Infectious Diseases 31

Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 31

National Taiwan University Hospital 32

Clinical Trial Overview of National Taiwan University Hospital 32

Queen Mary Hospital 33

Clinical Trial Overview of Queen Mary Hospital 33

Hospital Authority 34

Clinical Trial Overview of Hospital Authority 34

Queen's University 35

Clinical Trial Overview of Queen's University 35

Five Key Clinical Profiles 36

Appendix 58

Abbreviations 58

Definitions 58

Research Methodology 59

Secondary Research 59

About GlobalData 60

Contact Us 60

Disclaimer 60

Source 61

List of Tables

Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics, Global, Clinical Trials by Region, 2014* 7

Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8

Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9

Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 10

Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics Clinical Trials, Europe, Top Countries, 2014* 11

Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics Clinical Trials, North America, Top Countries, 2014* 12

Proportion of Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection to Infectious Disease Clinical Trials, G7 Countries (%), 2014* 13

Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14

Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15

Proportion of Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection to Infectious Disease Clinical Trials, E7 Countries (%), 2014* 16

Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 17

Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 18

Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics, Global, Clinical Trials by Phase, 2014* 19

Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 20

Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics, Global, Clinical Trials by Trial Status, 2014* 21

Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics Clinical Trials, Global, by End Point Status, 2014* 22

Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics, Global, Withdrawn Clinical Trials, 2014* 23

Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 24

Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 25

Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 26

Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 27

Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 28

Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by Pharmstandard, 2014* 29

Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by Hemispherx Biopharma, Inc., 2014* 30

Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2014* 31

Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2014* 32

Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by Queen Mary Hospital, 2014* 33

Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospital Authority, 2014* 34

Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by Queen's University, 2014* 35

List of Figures

Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics, Global, Clinical Trials by Region (%), 2014* 7

Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8

Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9

Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014* 10

Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12

Proportion of Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection to Infectious Disease Clinical Trials, G7 Countries (%), 2014* 13

Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14

Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15

Proportion of Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection to Infectious Disease Clinical Trials, E7 Countries (%), 2014* 16

Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 17

Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 18

Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics, Global, Clinical Trials by Phase (%), 2014* 19

Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 20

Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics, Global, Clinical Trials by Trial Status, 2014* 21

Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 24

Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 25

Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 26

Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 27

Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 28

GlobalData Methodology 59

    Pricing

Discounts available for multiple report purchases.

reportstore@globaldata.com
+44 (0) 161 359 5813

Join our mailing list

Saved reports